PharmaLex Development Services, LLC
Pharmaceutical ManufacturingPennsylvania, United States11-50 Employees
PharmaLex Development Services, LLC is a US division of PharmaLex GMBH. PharmaLex and YES Group merged in 2016 to bring size and scale to their already successful drug development businesses. This US division was founded in 1998 (as Swiftwater Group) by a small group of seasoned pharmaceutical consultants and industry veterans with the express purpose of taking a fresh approach to helping clients succeed. Since that time, we have merged with a large European consulting firm, YES International, with whom we deliver coordinated, global, full-service drug development capabilities. We believe that the problems, challenges, and opportunities that our clients wrestle with will almost always be tackled from multiple directions. Major decisions need to be based on a thorough understanding of the implications of non-clinical evaluation, clinical study design, manufacturing process and control, and how regulatory bodies will view the work. This is especially important when planning and coordinating projects to meet global objectives. At PharmaLex Development Services, we cross-train our consultants so they understand the integrated relationship of pharmaceutical development disciplines; our consultants with clinical expertise also know how to anticipate and identify process and regulatory issues that are likely to arise, while our CMC experts can identify cost-effectiveness issues and other challenges that can emerge during non-clinical studies. Ensuring our team has this full-spectrum development expertise across functional areas is a key to our – and your – success. PharmaLex Development Services understands the tradeoff among time, money, and resources. Whether you are trying to meet investment milestones, beat competitors to the market, or create superior data, you can rely on PharmaLex Development Services to provide expert advice and service – on time and on budget.
1-888-653-2347 
support@leadiq.com 
